» Articles » PMID: 29536371

Functional Status and Well-Being in People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Compared with People with Multiple Sclerosis and Healthy Controls

Overview
Date 2018 Mar 15
PMID 29536371
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Background: People with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) continue to struggle to have their condition recognised as disabling in the face of public and professional prejudice and discrimination.

Objective: The aim of this study was to compare the functional status and well-being of people with well-characterised ME/CFS with people with multiple sclerosis (PWMS), as well as healthy controls (HCs).

Methods: In this cross-sectional study, we used data collected as part of the UK ME/CFS Biobank to compare actual participant scores from the Medical Outcomes Survey Short Form-36 v2™ (SF-36v2™) between groups, as a proxy for impact of disability, and from a bespoke questionnaire seeking data on employment and income.

Results: People with ME/CFS scored significantly lower than PWMS or HCs in almost all SF-36v2™ areas. Prominent were lower scores for people with ME/CFS in the Physical Component Summary and Role Physical and Social Function domains, while the smallest differences were seen in the Mental Health domain. Responses to the bespoke questionnaire indicated that people with ME/CFS in this study work fewer hours and have lower incomes compared with people in the other two groups.

Conclusions: Using SF-36v2™ scores as a proxy, people with ME/CFS were measurably more disabled than PWMS or HCs in this study population. Furthermore, employment and income data are consistent with loss of functional status. These findings should encourage the health community to recognise the disabling effects of ME/CFS, to advocate for the needs of people with ME/CFS, and to investigate strategies to address the cost of the disease to both individuals and society.

Citing Articles

The search for a blood-based biomarker for Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (ME/CFS): from biochemistry to electrophysiology.

Clarke K, Kingdon C, Hughes M, Lacerda E, Lewis R, Kruchek E J Transl Med. 2025; 23(1):149.

PMID: 39905423 PMC: 11792299. DOI: 10.1186/s12967-025-06146-6.


Development and Implementation of an Online Patient Education Program for Children and Adolescents With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, Their Parents, Siblings, and School Personnel: Protocol for the Prospective BAYNET FOR ME/CFS....

Keicher F, Thomann J, Erlenwein J, Schottdorf M, Reiter N, Scholz-Schwarzler N JMIR Res Protoc. 2024; 13:e54679.

PMID: 39570662 PMC: 11621712. DOI: 10.2196/54679.


Impacts of Long COVID on workers: A longitudinal study of employment exit, work hours and mental health in the UK.

Reuschke D, Houston D, Sissons P PLoS One. 2024; 19(6):e0306122.

PMID: 38924025 PMC: 11207153. DOI: 10.1371/journal.pone.0306122.


Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: the biology of a neglected disease.

Arron H, Marsh B, Kell D, Khan M, Jaeger B, Pretorius E Front Immunol. 2024; 15:1386607.

PMID: 38887284 PMC: 11180809. DOI: 10.3389/fimmu.2024.1386607.


[Interdisciplinary, collaborative D-A-CH (Germany, Austria and Switzerland) consensus statement concerning the diagnostic and treatment of myalgic encephalomyelitis/chronic fatigue syndrome].

Hoffmann K, Hainzl A, Stingl M, Kurz K, Biesenbach B, Bammer C Wien Klin Wochenschr. 2024; 136(Suppl 5):103-123.

PMID: 38743348 PMC: 11093804. DOI: 10.1007/s00508-024-02372-y.


References
1.
Thomas M, Smith A . Primary healthcare provision and Chronic Fatigue Syndrome: a survey of patients' and General Practitioners' beliefs. BMC Fam Pract. 2005; 6:49. PMC: 1325235. DOI: 10.1186/1471-2296-6-49. View

2.
Dinos S, Khoshaba B, Ashby D, White P, Nazroo J, Wessely S . A systematic review of chronic fatigue, its syndromes and ethnicity: prevalence, severity, co-morbidity and coping. Int J Epidemiol. 2009; 38(6):1554-70. DOI: 10.1093/ije/dyp147. View

3.
Baker R, Shaw E . Diagnosis and management of chronic fatigue syndrome or myalgic encephalomyelitis (or encephalopathy): summary of NICE guidance. BMJ. 2007; 335(7617):446-8. PMC: 1962830. DOI: 10.1136/bmj.39302.509005.AE. View

4.
Ware J, Kosinski M . Interpreting SF-36 summary health measures: a response. Qual Life Res. 2002; 10(5):405-13; discussion 415-20. DOI: 10.1023/a:1012588218728. View

5.
Johns M . A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991; 14(6):540-5. DOI: 10.1093/sleep/14.6.540. View